Regeneron Pharmaceuticals, Inc (REGN) Stock Price

583.76 ▲ +11.38 (+1.99%)
Open: 575.065 Vol: 279 Day's range: 570.69 - 584.68 Aug 26, 12:40 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
REGN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 584.93▲ 581.36▲ 579.62▲ 587.29▼ 575.44▲
MA10 584.16▲ 578.11▲ 577.92▲ 579.01▲ 561.89▲
MA20 581.97▲ 578.09▲ 586.07▼ 568.54▲ 556.16▲
MA50 578.24▲ 589.40▼ 584.84▲ 552.51▲ 682.59▼
MA100 577.16▲ 584.03▲ 572.79▲ 558.10▲ 822.26▼
MA200 585.39▲ 572.58▲ 565.92▲ 635.05▼ 763.11▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.206▲ 1.620▲ -0.398▼ 1.346▲ 16.144▲
RSI 79.031▲ 57.701▲ 51.962▲ 57.219▲ 47.576▼
STOCH 91.228▲ 95.838▲ 44.954     66.499     78.131    
WILL %R -1.938▲ -0.841▲ -41.298     -37.743     -18.677▲
CCI 113.207▲ 188.176▲ 52.175     41.677     104.255▲
Latest Filters Detected On REGN
MA $REGN Price Crossed Above MA(7) Set Alert
Regeneron Pharmaceuticals, Inc News
The FDA Extends the Review Deadlines for Two Submissions by Regeneron Pharmaceuticals (REGN)
Tuesday, August 26, 2025 05:39 AM
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued US Stocks According to Wall Street Analysts. On August 20, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that the ...
Regeneron posts late-stage trial win for myasthenia gravis drug developed with Alnylam
Tuesday, August 26, 2025 05:13 AM
Regeneron Pharmaceuticals (NASDAQ:REGN) announced on Tuesday that a Phase 3 trial for its RNA-based therapy cemdisiran, developed with Alnylam Pharmaceuticals (NASDAQ:ALNY), succeeded in a late-stage ...
Immuneering signs supply deal with Lilly to test atebimetinib plus olomorasib
Monday, August 25, 2025 06:47 AM
Immuneering (IMRX) partners with Eli Lilly to test atebimetinib + olomorasib in a phase 2 trial targeting KRAS G12c-mutant lung cancer. Read more here.
REGN historical stock data
date open high low close volume
26/08/25 575.065 585.555 570.69 585.43 366,423
25/08/25 591.06 594.88 572.25 572.38 880,900
22/08/25 602.35 610.45 585.50 589.48 1,438,700
21/08/25 586.87 605.18 585.10 598.16 1,010,000
20/08/25 572.33 596.92 570.39 591.01 1,298,500
19/08/25 575.30 581.69 570.80 571.78 854,600
18/08/25 582.09 585.00 573.81 573.91 768,200
15/08/25 577.96 581.95 570.84 580.41 1,121,700
14/08/25 560.90 573.49 558.00 565.97 975,300
13/08/25 557.08 565.50 552.00 561.55 1,096,100
Quote Details
52wk Low:476.49
52wk High:1,192.54
Vol:279
Avg Vol(3m):21.9M
1Y Chng:-48.71%
1M Chng:+6.84%
Add to Watch List
More Information
Market Cap. 62.48B